β2-microglobulin for risk stratification of total mortality in the elderly population: Comparison with cystatin C and C-reactive protein

Shoji Shinkai, Paulo H.M. Chaves, Yoshinori Fujiwara, Shuichiro Watanabe, Hiroshi Shibata, Hideyo Yoshida, Takao Suzuki

Research output: Contribution to journalArticlepeer-review

Abstract

Background: The clinicoepidemiologic relevance of moderately elevated concentrations of circulating β2-microglobulin (β2-M) has not been established. Methods: We examined whether serum β2-M concentration independently predicts total mortality in community-dwelling older populations and compared its predictive value with that of cystatin C and C-reactive protein (CRP) using a prospective cohort study of 1034 initially nondisabled persons 65 years and older as part of the Tokyo Metropolitan Institute of Geronotology Longitudinal Interdisciplinary Study on Aging. Cox proportional hazards models were used to examine independent associations between baseline β2-M levels and total mortality. Results: During a median follow-up of 7.9 years, 223 persons died. A strong dose-response relationship was found between baseline serum β2-M concentration and mortality risk, even after multiple adjustments. Compared with individuals in the lowest tertile of serum β2-M concentration, those in the middle (hazard ratio, 2.02; 95% confidence interval [CI], 1.35-3.04) and highest (hazard ratio, 2.84; 95% CI, 1.92-4.20) tertiles had a substantially increased mortality risk. Respective values were 1.28 (95% CI, 0.86-1.90) and 1.95 (95% CI, 1.31-2.89) for cystatin C and 1.39 (95% CI, 0.98-1.98) and 1.44 (95% CI, 1.00-2.06) for CRP; only the highest tertiles showed significantly higher mortality risks. The area under the receiver operating characteristic curve for 8-year mortality was greatest for β2-M (0.70; 95% CI, 0.66-0.74), followed by cystatin C (0.66; 95% CI, 0.62-0.70) and CRP (0.57; 95% CI, 0.53-0.61). Additional adjustment for renal function measures, inflammation markers, or both only partially reduced the association between β2-M and mortality. Conclusion: Serum β2-M is an independent predictor of total mortality in a general population of older adults and may be a better predictor than cystatin C or CRP.

Original languageEnglish (US)
Pages (from-to)200-206
Number of pages7
JournalArchives of internal medicine
Volume168
Issue number2
DOIs
StatePublished - Jan 28 2008

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'β<sub>2</sub>-microglobulin for risk stratification of total mortality in the elderly population: Comparison with cystatin C and C-reactive protein'. Together they form a unique fingerprint.

Cite this